⌘K

Home/Filings/4/0000950170-25-030904

4//SEC Filing

D'Onofrio Matthew J 4

Accession 0000950170-25-030904

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:30 PM ET

Size

4.8 KB

Accession

0000950170-25-030904

Insider Transaction Report

Form 4

Period: 2025-02-28

Evoke Pharma IncEVOK

D'Onofrio Matthew J

Exec VP, Chief Bus. Officer

Transactions

Award
Common Stock
2025-02-28$3.65/sh+6,849$24,999→ 8,820 total

Footnotes (1)

[F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c) and Rule 16b-3(d).

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1

filerCIK 0001578770

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 4:30 PM ET
Size: 4.8 KB

View on SEC.gov